The informed consent model is an approach to transgender healthcare that prioritises patient autonomy and removes traditional barriers to treatment. Evidence from healthcare organisations shows this model starts from a fundamental position of believing transgender people when they identify who they are, rather than requiring extensive gatekeeping or lengthy assessment processes.
Research indicates that this approach focuses on providing clear, comprehensive information about treatment options and their effects, then supporting people to make informed decisions about their own care. The model recognises that transgender individuals are the experts on their own experiences and identities, eliminating the need to prove their gender identity to medical professionals.
Guidelines from leading transgender health organisations demonstrate that informed consent models can significantly reduce waiting times and psychological distress often associated with traditional assessment pathways. The approach asks 'how can we help?' rather than 'can you prove who you are?', which studies suggest leads to better patient outcomes and satisfaction.
This model represents a shift towards patient-centred care that acknowledges the expertise individuals have about their own gender identity. People often ask about this approach because it offers a more accessible pathway to gender-affirming treatment whilst maintaining appropriate medical safeguards through thorough informed consent processes.